The equipments were purchased according to the Hungarian tender regulations before 2005. The last (5th) one was advertised after the admittance of Hungary by the European Union. This 5th tender had to be advertised and evaluated according to the EU tender regulations. This modification has resulted in considerable delay in the process.
Altogether 116 different kinds of equipments have been installed into the regional laboratories and top institutions supported by the PHARE programme:
In addition to the one- or two-week trainings offered by the manufacturers according to the tender advertisements, short term (1 week) and long term (more than one month) fellowships have been offered for the co-workers in order to visit different institutions which possess experts in the fields to be studied.
Finally, a twinning light project (for 118,000) has been won by the Ministry of Northern Westfalen in Germany, who have prepared an excellent review on the Hungarian epidemiological situation in comparison to those of 5 EU member states.Eight experts visited one or more times Hungary and gave lectures of high scientific level on the fields, we plan to introduce or continue utilising the PHARE investments.Trainings have been also held on the laboratory technologies required under the working conditions of BSL4 and BSL3 facilities.
This is to thank for the European Union for the PHARE projects, and for the support promoting the Hungarian microbiological diagnostic activities.
The official permission for the start of the BSL4/BSL3 work was obtained by 26th of June 2006. The authorities have recommended a test operation of 180 days with inocuous organisms. Vaccine-like live polioviruses have been introduced into the laboratory first with the necessary tissue culture work.Wild polioviruses isolated before 1973 in the country have been transferred from the previous laboratories into a deep freezer located within the hypotonic laboratory region of the BSL4 facility.Following the request of the European Headquarter of WHO two shipments of vaccine associated paralytic poliomyelitis were mailed in July to the Centers for Disease Control, Atlanta, Georgia for the molecular examination of the viruses. These viruses will contribute to the next phases of the global eradication of poliomyelitis guided by the WHO.
Structure of NCE
Bulletin of NCE
Our outstanding scientists
NCE - as training site
Library of NCE